CURA_1170x120

Revlon to buy Elizabeth Arden for $870 million

Revlon to buy Elizabeth Arden for $870 million

NEW YORK — Revlon Inc. is acquiring Elizabeth Arden Inc. in a deal valued at approximately $870 million. Revlon said that under the agreement, announced late Thursday, it will acquire all of the outstanding shares of Elizabeth Arden for $14 per share in cash, , which represents a 50% premium over Elizabeth Arden’s closing share

Former Walgreens exec Curtin to join Coty

Former Walgreens exec Curtin to join Coty

NEW YORK — Shannon Curtin, former group vice president of beauty and personal care at Walgreen Co., is joining Coty Inc. as senior vice president for North America. Coty said Friday that Curtin will assume her new position after the completion of the company’s merger with Procter & Gamble Specialty Beauty. In the interim, she

Pfizer, Allergan abandon $160 billion merger plan

Pfizer, Allergan abandon $160 billion merger plan

NEW YORK — Pfizer Inc. said Wednesday that its merger agreement with Allergan PLC has been terminated by mutual agreement, a decision driven by the Treasury Department’s announcement of new rules intended to undercut this type of tax inversion deal. The move is a major victory for the Obama administration in its campaign against inversions,

Walmart names health and wellness VP

Walmart names health and wellness VP

BENTONVILLE, Ark. — Marcus Osborne has been appointed as vice president of health and wellness transformation at Walmart. Walmart confirmed Osborne’s promotion on Wednesday. He previously served as vice president of health and wellness payer relations. In his new role, Osborne will focus on driving the strategic vision, business development and key initiatives for the

McKesson to acquire Rexall for $1.9 billion

McKesson to acquire Rexall for $1.9 billion

TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $1.9 billion ($3 billion Canadian). McKesson and Katz Group said Wednesday that the deal will strengthen McKesson’s position in Canada’s pharmaceutical supply chain and is described as a natural step for two companies that have worked together for